These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 698971)
1. Some comments on the necessity of receptor determination in human breast cancer. Jonat W; Maass H Cancer Res; 1978 Nov; 38(11 Pt 2):4305-6. PubMed ID: 698971 [TBL] [Abstract][Full Text] [Related]
2. Clinical correlations of steroid receptors and male breast cancer. Everson RB; Lippman ME; Thompson EB; McGuire WL; Wittliff JL; De Sombre ER; Jensen EV; Singhakowinta A; Brooks SC; Neifeld JP Cancer Res; 1980 Apr; 40(4):991-7. PubMed ID: 7357565 [TBL] [Abstract][Full Text] [Related]
3. Steroid receptors in breast cancer. Desombre ER Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047 [TBL] [Abstract][Full Text] [Related]
4. Role of pituitary hormones in the growth of human breast cancer. Pearson OH; Manni A; Chambers M; Brodkey J; Marshall JS Cancer Res; 1978 Nov; 38(11 Pt 2):4323-6. PubMed ID: 212192 [TBL] [Abstract][Full Text] [Related]
5. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. McClelland RA; Finlay P; Walker KJ; Nicholson D; Robertson JF; Blamey RW; Nicholson RI Cancer Res; 1990 Jun; 50(12):3545-50. PubMed ID: 2187598 [TBL] [Abstract][Full Text] [Related]
6. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012 [TBL] [Abstract][Full Text] [Related]
7. Steroid receptors in human breast cancer. McGuire WL Cancer Res; 1978 Nov; 38(11 Pt 2):4289-91. PubMed ID: 698967 [TBL] [Abstract][Full Text] [Related]
8. The NFkappaB pathway and endocrine-resistant breast cancer. Zhou Y; Eppenberger-Castori S; Eppenberger U; Benz CC Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S37-46. PubMed ID: 16113098 [TBL] [Abstract][Full Text] [Related]
9. Hormone receptors and Japanese breast cancer. Matsumoto K; Kitamura Y; Sugano H Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994 [TBL] [Abstract][Full Text] [Related]
10. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction. Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476 [TBL] [Abstract][Full Text] [Related]
11. [Place of hormone receptor determination in the therapeutic strategy of breast cancer]. Clavel B; Gest J Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702 [TBL] [Abstract][Full Text] [Related]
12. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391 [TBL] [Abstract][Full Text] [Related]
13. Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer. Andre F; Hatzis C; Anderson K; Sotiriou C; Mazouni C; Mejia J; Wang B; Hortobagyi GN; Symmans WF; Pusztai L Clin Cancer Res; 2007 Apr; 13(7):2061-7. PubMed ID: 17404087 [TBL] [Abstract][Full Text] [Related]
14. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP. Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274 [TBL] [Abstract][Full Text] [Related]
15. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B; J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359 [TBL] [Abstract][Full Text] [Related]
16. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers. Kurbel S Med Hypotheses; 2005; 64(6):1182-7. PubMed ID: 15823713 [TBL] [Abstract][Full Text] [Related]
17. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer. Allegra JC; Lippman ME; Thompson EB; Simon R Cancer Res; 1978 Nov; 38(11 Pt 2):4299-304. PubMed ID: 698970 [No Abstract] [Full Text] [Related]
18. [Steroid receptors and breast carcinoma]. Pasić R; Dulbegović B; Softić D; Wittlif JL Med Pregl; 1991; 44(1-2):48-51. PubMed ID: 1870463 [TBL] [Abstract][Full Text] [Related]
19. Biologic basis of sequential and combination therapies for hormone-responsive breast cancer. Pietras RJ Oncologist; 2006; 11(7):704-17. PubMed ID: 16880230 [TBL] [Abstract][Full Text] [Related]
20. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]